Intellia Therapeutics Inc buy Royal Bank of Canada
Start price
10.11.23
/
50%
€22.58
Target price
10.11.24
€65.49
Performance (%)
-30.16%
End price
11.11.24
€15.77
Summary
This prediction ended on 11.11.24 with a price of €15.77. Massive losses of -30.16% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.634% | -3.634% | -1.932% |
| iShares Core DAX® | 0,46 % | -1,53 % | 9,99 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % | -0,88 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % | 30,03 % |
| iShares S&P 500 | -1,76 % | -3,82 % | -0,21 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank of Canada from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.24
08.08.25
08.08.25
€18.01
08.08.26
08.08.26
7.41%
09:23
09:23
Stopped prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€20.95
19.09.24
19.09.24
€48.55
19.09.25
19.09.25
-35.54%
20.09.25
20.09.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€19.65
09.08.24
09.08.24
€49.44
09.08.25
09.08.25
-52.65%
10.08.25
10.08.25